Details werden geladen...
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection | The Manila Times
Breakthrough Therapy Designation granted for pevifoscorvir sodium in China
Ähnliche Seiten
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection - PubMed
https://pubmed.ncbi.nlm.nih.gov/42206582/
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) | The Manila Times
https://www.manilatimes.net/2026/06/22/tmt-newswire/globenewswire/prime-medicine-receives-us-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-pm359-for-the-treatment-of-chronic-granulomatous-disease-cgd/2370056Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE | The Manila Times
https://www.manilatimes.net/2026/06/22/tmt-newswire/pr-newswire/antengene-announces-exclusive-license-agreement-with-mpm-bioimpact-established-k2-therapeutics-for-atg-106-and-option-for-undisclosed-bispecific-tce/2369714Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease | The Manila Times
https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/monopar-therapeutics-receives-fda-rare-pediatric-disease-designation-for-alxn1840-for-the-treatment-of-wilson-disease/2375713
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China | The Manila Times
https://www.manilatimes.net/2026/06/08/tmt-newswire/globenewswire/telitacicept-receives-nmpa-conditional-approval-for-the-treatment-of-iga-nephropathy-in-china/2360795